ESC Premium Access

COMMANDER HF - Randomized Study Comparing Rivaroxaban with Placebo in Subjects with Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure

Congress Presentation

About the speaker

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)
95 presentations
1 follower

19 more presentations in this session

Opening question - ATTR-ACT Trial.

Thumbnail

ATTR-ACT Trial - Efficacy and Safety of Tafamidis in Transthyretin Amyloid Cardiomyopathy

Speaker: Professor C. Rapezzi (Ferrara, IT)

Thumbnail

Discussant review - ATTR-ACT.

Speaker: Professor J. George (Rehovot, IL)

Thumbnail

Questions from the audience and discussion.

Thumbnail

Concluding question - ATTR-ACT Trial.

Thumbnail

Access the full session

Hot Line Session 3

Speakers: Professor F. Zannad, Professor C. Rapezzi, Professor J. George
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb